This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
marijuana: Archive
5 Trendy Earnings Charts
by Tracey Ryniec
Are cannabis and solar stocks still the place to be for traders in 2019?
CSIQPositive Net Change CGCNegative Net Change TLRYPositive Net Change CRONNegative Net Change ACBPositive Net Change
cannabis earnings marijuana solar
What's in Store for Aurora Cannabis' (ACB) Q1 Earnings?
by Zacks Equity Research
Solid prospects in the Canadian and international markets are expected to have driven Aurora Cannabis' (ACB) fiscal first-quarter performance.
BMOPositive Net Change CCLPositive Net Change ACBPositive Net Change CGCNegative Net Change
marijuana medical
Tilray (TLRY) Set to Report Q3 Results: Will the Stock Continue to Plunge?
by Christopher Vargas
Tilray (TLRY) is set to report its third quarter results after the closing bell Tuesday, November 12.
NVSNegative Net Change BUDPositive Net Change TLRYPositive Net Change
earnings emerging-markets marijuana
Aurora Cannabis (ACB) Q1 Earnings on Deck: Can Things Turnaround?
by Christopher Vargas
Aurora Cannabis (ACB) is set to report its first quarter results after the closing bell Thursday, November 14th.
ACBPositive Net Change
earnings emerging-markets marijuana
U.S.-China Trade Progress, Q3 Earnings Results & Buy Yeti Stock - Free Lunch
by Benjamin Rains
The latest U.S.-China trade war news that could see the world's two largest economies roll back tariffs. Q3 earnings results from the likes of Qualcomm and Square. And why Yeti is a Zacks Rank #1 (Strong Buy) stock...
DISNegative Net Change TRIPPositive Net Change EXPEPositive Net Change NFLXNegative Net Change AMZNNegative Net Change SQPositive Net Change QCOMNegative Net Change AAPLNegative Net Change LULUPositive Net Change RLPositive Net Change CGCNegative Net Change ACBPositive Net Change CRONNegative Net Change TLRYPositive Net Change YPositive Net Change
business-services cryptocurrency earnings marijuana retail tech-stocks
Cronos (CRON) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress, when it reports Q3 results.
CGCNegative Net Change CRONNegative Net Change
marijuana medical
Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports third-quarter 2019 results.
CGCNegative Net Change TLRYPositive Net Change
marijuana medical
Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
by Benjamin Rains
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
TAPPositive Net Change STZPositive Net Change GWPHPositive Net Change SMGPositive Net Change MOPositive Net Change IIPRPositive Net Change APHANegative Net Change ACBPositive Net Change CRONNegative Net Change TLRYPositive Net Change CGCNegative Net Change MJNegative Net Change
earnings marijuana
4 Highly-Ranked Cheap Stocks Trading Under $10 to Buy Right Now
by Benjamin Rains
Today we highlighted 4 'cheap' stocks that are currently trading for under $10 per share that also sport a Zacks Rank #2 (Buy) or better that investors might want to consider buying right now...
FROPositive Net Change ZNGAPositive Net Change SNAPNegative Net Change ACBPositive Net Change CGCNegative Net Change CRONNegative Net Change TLRYPositive Net Change
earnings finance gold internet-content marijuana tech-stocks
Marijuana Stocks to Buy or Avoid in November
by Tirthankar Chakraborty
We highlight three marijuana stocks that look like solid bargains, while one in particular should be avoided in the near future.
SQPositive Net Change CTSTPositive Net Change OGINegative Net Change HEXOPositive Net Change
marijuana